AeroLeads people directory · profile

Martin Munte Email & Phone Number

Location: Lugano, Ticino, Switzerland 12 work roles 1 school
2 work emails found @amgen.com 2 phones found area 805 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails · 2 phones

Work email m****@amgen.com
Direct phone (805) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO
Location
Lugano, Ticino, Switzerland

Who is Martin Munte? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Martin Munte is listed as CEO at Vaccentis, based in Lugano, Ticino, Switzerland. AeroLeads shows a work email signal at amgen.com, phone signal with area code 805, and a matched LinkedIn profile for Martin Munte.

Martin Munte previously worked as Senior Executive Consultant & Advisor at Life Sciences (Pharma + Biotech + Medtech) and External Access Engagement Lead Europe at Amgen. Martin Munte holds Master, Handelswissenschaften from Wu (Vienna University Of Economics And Business).

Company email context

Email format at Vaccentis

This section adds company-level context without repeating Martin Munte's masked contact details.

{first}.{last}@amgen.com
89% confidence

AeroLeads found 2 current-domain work email signals for Martin Munte. Compare company email patterns before reaching out.

Profile bio

About Martin Munte

Experienced Leader in Pharma/Biotech in Europe with special focus on the Big 5 markets, Country General Management in mid-sized markets and Pharma association leadership. High impact negotiator with key stakeholders, skilled C-suite communicator & presenter. Clear definer & executor of Business Development strategies and go to market models. Successful P&L track record, proven coaching & talent management. High organizational, change management skills and capabilities with impactful implementation of key strategies. Commercial, Sales & Marketing, Market Access, Pricing, Business Development and Regulatory Affairs senior leadership.

Listed skills include Biotechnologie, Pharmaindustrie, Management, Arzneimittelverkauf, and 8 others.

Current workplace

Martin Munte's current company

Company context helps verify the profile and gives searchers a useful next step.

Vaccentis
Vaccentis
CEO
AeroLeads page
12 roles

Martin Munte work experience

A career timeline built from the work history available for this profile.

Ceo

Current

Zürich, Switzerland, CH

Vaccentis AG is a clinical-stage Swiss biopharmaceutical company developing patient-specific medicines to improve patients’ chances of recovery from chronic and malignant diseases. Vaccentis’ product pipeline includes VCC-001, Autologous Serum Eye Drops (ASAT), Individual Immunotherapy, and Urexent®. VCC-001 is in clinical development to treat.

Jul 2022 - Present

Senior Executive Consultant & Advisor

  • SCOPE OF SERVICES:STRATEGIC ASSESSMENTS AND PLANS
  • Macroeconomic analysis - health care environment
  • Strategy and portfolio assessment
  • Scenario analysis and impact assessments
  • Go-to-market launch models
  • Growth strategy plans – Innovative and BiosimilarsORGANIZATIONAL EXCELLENCE & EFFECTIVENESS
Sep 2021 - Jun 2022

External Access Engagement Lead Europe

Thousand Oaks, CA, US

  • Leading all European Policy, Government Affairs and Professional Associations efforts for EU-Stakeholder and Business management to achieve optimal Access
  • Implementing key Policy activities and changes to shape the Access Environment and to enable optimal Access for the Amgen Brand, Biosimilar and Pipeline products
  • Provide strategic and tactical advice based on key Policy Priorities for affiliates
  • Develop/ collect and provide policy material to regional brand teams and affiliates
  • Lead or support related activities/ projects (as part of a cross-functional team)
  • Identification of EU policy trends and priorities
Jun 2019 - Sep 2021

General Manager

Thousand Oaks, CA, US

  • 115 Employees, 120 $M sales
  • Managing Director with full P&L responsibility and Executive Director under trade law
  • All product launches successfully reimbursed with optimal patient access from 2009 to 2019
  • Sales doubled and profit tripled in period
  • New indications launched: Bone, Cardio, Biosimilars with MS leadership
Jul 2009 - Jun 2019

General Manager Amgen Slovakia

Thousand Oaks, CA, US

  • 45 employees, 45 $M sales
  • Successful reimbursement and launch for innovative products
  • Highest MS for Bone in Europe
Oct 2017 - Sep 2018

General Manager Amgen İlaç, Istanbul

Thousand Oaks, CA, US

  • 60 Amgen + 1400 MN employees
  • Sales turnaround from 20 $M to 60 $M
  • Built up of Amgen Oncology business, fostered the MN integration, reintegration of GCSF business from Roche and launch of innovative Amgen products
  • Led Amgen Turkey to its first year of profit (from -12 $M to +20 $M)
Oct 2013 - Oct 2014

Marketing & Sales Director Specialty Care

Cambridge, Cambridgeshire, GB

  • Member of the Leadership team, Executive Secretary
  • Direct P&L Responsibility for Oncology and CNS Business Units
Jul 2007 - Jun 2009

Market Access, Regulatory & Business Development Director

Cambridge, Cambridgeshire, GB

  • Member of the Leadership team, Executive Secretary
  • Responsible for Market Access, Regulatory and Business Development & Pricing
Sep 2004 - Jun 2008

Marketing Manager Primary Care

Cambridge, Cambridgeshire, GB

  • Head of Marketing Cardiovascular, Gastrointestinal, Respiratory and Hospital
  • Leadership, Coaching and Development of 17 Managers within the Marketing Primary Care Department
Sep 2002 - Aug 2004

Sales Manager

Switzerland 🇨🇭, CH

  • Cardio/Osteoporosis Region East/South
  • Leadership, Coaching and Development of 9 Field Representatives
May 2001 - Aug 2002

Produkt Manager

Switzerland 🇨🇭, CH

  • Responsible for the Launch of the neuraminidase inhibitor Tamiflu for Influenza, for Infection and Anaesthesia
Mar 2000 - Apr 2001

Product Spezialist, Product Manager Und Team Leader

Cambridge, Cambridgeshire, GB

  • Project Manager for the new AstraZeneca Sales Force Organization
  • Coordinator of the Focus Merger Project
  • Member of the Marketing & Sales Task Force
  • Member of the site selection team 05/1997 - 06/1999 Field Product Specialist Hospital
  • Product Management and Field Representative at the University Hospital Graz
May 1997 - Feb 2000
1 education record

Martin Munte education

  • Wu (Vienna University Of Economics And Business)
    Wu (Vienna University Of Economics And Business)
    Handelswissenschaften
FAQ

Frequently asked questions about Martin Munte

Quick answers generated from the profile data available on this page.

What company does Martin Munte work for?

Martin Munte works for Vaccentis.

What is Martin Munte's role at Vaccentis?

Martin Munte is listed as CEO at Vaccentis.

What is Martin Munte's email address?

AeroLeads has found 2 work email signals at @amgen.com for Martin Munte at Vaccentis.

What is Martin Munte's phone number?

AeroLeads has found 2 phone signal(s) with area code 805 for Martin Munte at Vaccentis.

Where is Martin Munte based?

Martin Munte is based in Lugano, Ticino, Switzerland while working with Vaccentis.

What companies has Martin Munte worked for?

Martin Munte has worked for Vaccentis, Life Sciences (Pharma + Biotech + Medtech), Amgen, Astrazeneca, and Roche.

How can I contact Martin Munte?

You can use AeroLeads to view verified contact signals for Martin Munte at Vaccentis, including work email, phone, and LinkedIn data when available.

What schools did Martin Munte attend?

Martin Munte holds Master, Handelswissenschaften from Wu (Vienna University Of Economics And Business).

What skills is Martin Munte known for?

Martin Munte is listed with skills including Biotechnologie, Pharmaindustrie, Management, Arzneimittelverkauf, Marktzugang, Cross Functional Team Leadership, Biotechnology, and Pharmaceutical Industry.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.